Key Takeaway
GLP-1 medications should be stopped before trying to conceive. Learn about washout periods, how GLP-1 weight loss can improve fertility, PCOS effects, and contraception guidance across the drug class.
GLP-1 receptor agonists should be discontinued before attempting pregnancy. The exact washout period varies by medication: semaglutide products require at least two months, while tirzepatide products need at least one month. Despite this restriction, the weight loss these medications enable can significantly improve fertility for patients struggling with obesity-related reproductive problems.
The GLP-1 medication class includes semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), and several others. All of them carry pregnancy-related precautions, and all of them can produce metabolic changes that benefit reproductive health indirectly. Understanding the class-wide picture helps you make informed decisions regardless of which specific GLP-1 you're taking.
Why GLP-1 Medications Are Stopped Before Pregnancy
None of the currently available GLP-1 receptor agonists are approved for use during pregnancy. Animal reproductive studies across the class have shown adverse developmental effects at doses above human therapeutic ranges, including embryonic loss, reduced fetal growth, and skeletal abnormalities.
Human pregnancy data is limited for all GLP-1 medications because pregnant women are excluded from clinical trials. The washout recommendations are precautionary, designed to ensure the drug is cleared before conception occurs. Different half-lives across the class dictate different washout timelines:
- Semaglutide (Ozempic, Wegovy, compounded): approximately 7-day half-life, 2-month washout
- Tirzepatide (Mounjaro, Zepbound): approximately 5-day half-life, 1-month washout
- Liraglutide (Saxenda, Victoza): approximately 13-hour half-life, shorter washout (consult provider)
The Fertility Paradox: GLP-1 Weight Loss as a Fertility Treatment
While GLP-1 medications must be stopped before pregnancy, the weight loss they produce can be one of the most effective pre-conception interventions available. Obesity affects fertility through several interconnected mechanisms:
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
- Excess fat tissue produces estrogen, disrupting the hormonal signals that trigger ovulation
- Insulin resistance, common in obesity, impairs follicular development and egg maturation
- Chronic inflammation associated with excess weight reduces egg and sperm quality
- Higher BMI is linked to lower IVF success rates and higher miscarriage rates
By addressing these factors through meaningful weight loss, GLP-1 medications can create a more fertile foundation even though the drugs themselves can't be taken during pregnancy. Some reproductive endocrinologists have begun incorporating GLP-1 therapy into pre-conception planning for obese patients.
GLP-1 Medications and PCOS
PCOS is one of the most common causes of female infertility, affecting 8% to 13% of reproductive-age women globally. The condition is closely tied to insulin resistance and weight gain, making GLP-1 medications a particularly relevant treatment option.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Weight loss and improved insulin sensitivity from GLP-1 therapy can restore regular ovulation in many PCOS patients. This restoration can happen unexpectedly, leading to unplanned pregnancies in women who thought they couldn't conceive. If you have PCOS and are taking a GLP-1 medication without intending to become pregnant, use reliable contraception consistently.
Contraception Across the GLP-1 Class
All GLP-1 receptor agonists slow gastric emptying to varying degrees. This raises theoretical concerns about oral contraceptive pill absorption. Tirzepatide's prescribing information is the most explicit, recommending backup contraception for four weeks after initiation and dose changes. Semaglutide's label is less specific but acknowledges the possibility. Non-oral methods (IUDs, implants, injections, patches) bypass this concern entirely.
Frequently Asked Questions
Which GLP-1 medication is safest for fertility planning?
No GLP-1 medication is approved for use during pregnancy. For fertility planning purposes, liraglutide has the shortest half-life (about 13 hours) and thus the quickest clearance time. But the choice of GLP-1 should be based on your overall health needs, and any of them can be used with proper washout planning. Your provider can help determine the best approach. GLP-1 medications complete guide
Do GLP-1 medications cause permanent infertility?
No. There's no evidence that any GLP-1 receptor agonist causes permanent infertility in humans. The recommendation to stop before pregnancy is a precautionary measure based on animal studies. Many patients experience improved fertility after GLP-1 treatment due to the benefits of weight loss on reproductive health.
Can men take GLP-1 medications while trying to conceive with a partner?
The pregnancy warnings for GLP-1 medications apply to the person carrying the pregnancy, not to male partners. Men can generally continue GLP-1 therapy while their partner is trying to conceive. The weight loss may even improve male fertility by boosting testosterone and sperm quality. Discuss your specific situation with your provider.
What happens to my weight when I stop my GLP-1 for pregnancy?
Some weight regain is possible after stopping a GLP-1 medication. Maintaining healthy eating habits and regular physical activity during the washout period and pregnancy can help minimize regain. Your provider can help you develop a plan to sustain your progress during this transition.
Can I restart my GLP-1 medication after giving birth?
If you aren't breastfeeding, restarting a GLP-1 medication after delivery is generally possible once your provider clears you. If you're breastfeeding, GLP-1 medications aren't recommended because it's unknown whether they pass into breast milk. Discuss postpartum medication planning with your healthcare team.